// App-Quantinova.ai

: Genetic contribution to grey matter network disruptions and Alzheimer disease cerebrospinal fluid markers

Researchers

Presenter

  • Ellen Dicks

Principal Investigators

  • Jori Tomassen

  • Mara ten Kate

  • Charlotte E. Teunissen

  • Philip Scheltens

  • Frederik Barkhof

  • Anouk den Braber

  • Pieter Jelle Visser

  • Betty M. Tijms

Medical Centers

  • Maastricht University

  • Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC

  • Mayo Clinc

  • University CollegeLondon, UK

  • Karolinska Institutet,

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Alzheimer's disease

Biomarkers

  • Amyloid beta 40

  • Amyloid beta 42

  • Tau protein

  • Cerebrospinal fluid

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved